Codon 

€0.006500
0
-€0.00-7.14% 10:01 Today

Statistics

Day High
0.007
Day Low
0.0065
52W High
0.022
52W Low
0.006
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-2.42MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

co.don AG, a biopharmaceutical company, develops, produces, and markets biopharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide. It offers Spherox, a three-dimensional cartilage cell transplant product that is used to treat cartilage defects in adult knee joints and adolescents; and co.don chondrosphere for the treatment of cartilage defects in the hip, ankle, and shoulder and elbow. co.don AG was founded in 1993 and is headquartered in Teltow, Germany.
Show More
CEO
Employees
134
Country
Germany
ISIN
DE000A3E5C08
WKN
000A3E5C0

Listings

0 Comments

Share your thoughts

FAQs

What is Codon stock price today?▼
The current price of CNW.STU is €0.01 EUR — it has decreased by -7.14% in the past 24 hours. Watch Codon stock price performance more closely on the chart.
What is Codon stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Codon stocks are traded under the ticker CNW.STU.
Is Codon stock price growing?▼
CNW.STU stock has fallen by -7.14% compared to the previous week, the month change is a -13.33% fall, over the last year Codon has showed a -67.5% decrease.
What is Codon revenue for the last year?▼
Codon revenue for the last year amounts to 0 EUR.
What is Codon net income for the last year?▼
CNW.STU net income for the last year is -2.42M EUR.
How many employees does Codon have?▼
As of November 2, 2026, the company has 134 employees.
In which sector is Codon located?▼
Codon operates in the Energy sector.
When did Codon complete a stock split?▼
The last stock split for Codon was on October 29, 2013 with a ratio of 2:1.